Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia

被引：0
|
作者：
Guro F Giskeødegård
Ailin Falkmo Hansen
Helena Bertilsson
Susana Villa Gonzalez
Kåre Andre Kristiansen
Per Bruheim
Svein A Mjøs
Anders Angelsen
Tone Frost Bathen
May-Britt Tessem
机构：
[1] Norwegian University of Science and Technology (NTNU),Department of Circulation and Medical Imaging
[2] Trondheim 7491,Department of Cancer Research and Molecular Medicine
[3] Norway,Department of Urology
[4] St Olav University Hospital,Department of Chemistry
[5] Norwegian University of Science and Technology (NTNU),Department of Biotechnology
[6] NTNU,Department of Chemistry
[7] NTNU,undefined
[8] NTNU,undefined
[9] University of Bergen,undefined
来源：
British Journal of Cancer | 2015年 / 113卷
关键词：
metabolomics; serum; plasma; prostate cancer; MRS; MS; GC; acylcarnitines; glycerophospholipids; arginine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1712 / 1719
页数：7
相关论文
共 50 条
  • [31] Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China
    Lacey, JV
    Deng, J
    Dosemeci, M
    Gao, YT
    Mostofi, FK
    Sesterhenn, IA
    Xie, T
    Hsing, AW
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 (02) : 341 - 349
  • [32] The impact of benign prostatic hyperplasia on bladder volume in radiotherapy of prostate cancer
    Jang, H.
    Baek, J. G.
    Kwon, S. Y.
    Lee, K. S.
    Oh, Y. T.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2019, 17 (03): : 401 - 406
  • [33] Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia
    Lagiou, Areti
    Samoli, Evi
    Georgila, Christina
    Minaki, Ploumi
    Barbouni, Anastasia
    Tzonou, Anastasia
    Trichopoulos, Dimitrios
    Lagiou, Pagona
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2008, 17 (04) : 336 - 339
  • [34] Complexed and total PSA in patients with benign prostatic hyperplasia and prostate cancer
    Tamimi, W.
    Dafterdar, R.
    Mansi, M.
    Alsaad, K.
    Alarifi, S. A.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2010, 67 (04) : 184 - 188
  • [35] Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
    Hung, S-C
    Lai, S-W
    Tsai, P-Y
    Chen, P-C
    Wu, H-C
    Lin, W-H
    Sung, F-C
    BRITISH JOURNAL OF CANCER, 2013, 108 (09) : 1778 - 1783
  • [36] Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer
    Fawzy, Mohamed S.
    Mohamed, Randa H.
    Elfayoumi, Abdel-Rahman R.
    MEDICAL ONCOLOGY, 2015, 32 (03)
  • [37] Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer
    Mohamed S. Fawzy
    Randa H. Mohamed
    Abdel-Rahman R. Elfayoumi
    Medical Oncology, 2015, 32
  • [38] Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis)
    Lokant, M. T.
    Naz, R. K.
    ANDROLOGIA, 2015, 47 (03) : 328 - 332
  • [39] Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia
    Vicentini, C
    Gravina, GL
    Angelucci, A
    Pascale, E
    D'Ambrosio, E
    Muzi, P
    Leonardo, GD
    Fileni, A
    Tubaro, A
    Festuccia, C
    Bologna, M
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (04) : 217 - 221
  • [40] Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia
    Carlo Vicentini
    Giovanni Luca Gravina
    Adriano Angelucci
    Esterina Pascale
    Ettore D’Ambrosio
    Paola Muzi
    Gabriella Di Leonardo
    Antonio Fileni
    Andrea Tubaro
    Claudio Festuccia
    Mauro Bologna
    Journal of Cancer Research and Clinical Oncology, 2004, 130 : 217 - 221
12345